André Mercanzini is the founder of Aleva Neurotherapeutics. Aleva Neurotherapeutics has raised $70M in total funding. Latest round: Series E.
André Mercanzini is the CEO of Aleva Neurotherapeutics, a healthcare startup that has raised $70 million to pioneer deep brain stimulation. His company's technology helps neurosurgeons and neurologists by reducing surgical and follow-up times for patients with neurological disorders.
Full founder directory · Investor directory · Company funding database · Fundraising library